InvestorsHub Logo
Followers 313
Posts 14345
Boards Moderated 0
Alias Born 10/17/2013

Re: hitpaydirt post# 379

Thursday, 01/12/2017 8:10:56 PM

Thursday, January 12, 2017 8:10:56 PM

Post# of 22870
Wow, Here's some more info I found..

Ms. Kathleen Roberton has been the Chief Executive Officer, President and Director at Cantor Group Inc since January 14, 2016. Ms. Roberton has an extensive background as an Officer and Director of public companies.

http://www.bloomberg.com/research/stocks/people/person.asp?personId=322463071&privcapId=33364811

So that being said ....

Feb 2016 ...

This was in her bio..it said feb 2015, but she didn't even become CEO of MEDH until 2016...

Here's probably the next PR update of her completion....I'm sure of it...it has to be; ( 49 state licensing ) and guess what..... Its due in less than 3 weeks!!!

( smiling)!!!

MedX will advance to be licensed in up to 49 other states within the next 12 months.

MedX has structured agreements with Amneal Pharmaceuticals and Gemini Laboratories who are the FDA Approved Manufactures of Finished Dosed Drugs. Phase Two: We have 3 products to launch in the OTC realm, two we will manufacture and one we will have a licensing agreement on. This may prove to be our largest sector as a couple products are suited for Kathleen Roberton’s contacts who own very large network marketing companies.